FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
FEMASYS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.63−0.02 (-1.21%)
Close on Oct 19, 2026
- Market cap
- $5.47M
- P/E (TTM)
- –
- Dividend yield
- –
FEMASYS INC revenue by segment
By business segment
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | TTM Q2 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $1.41M | $1.42M | $1.39M | $1.33M | $1.26M | $1.14M | $1.07M | – | – | $1.01M | – | – | 61.2% | +11.7% |
| International [Member] | $892.56K | $957.32K | $899.76K | $727.91K | $627.56K | $555.60K | $555.60K | – | – | $58.05K | – | – | 38.8% | +42.2% |
From the segment and revenue-disaggregation notes of Femasys's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.